Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.

J Immunother Cancer · 2022 · PMC9413295 · PMID 36002183

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a trend toward worse RFS with ENE (24-month RFS 56% vs 68% without ENE; HR 1.72 (95% CI 0.86 to 3.45), p=0.12), which did not reach statistical significance perhaps due to only 9 patients with ENE in this group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.